8 results
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
information about the audit and the financial statements;
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy … statements and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
-down executive compensation disclosure requirements applicable to emerging growth companies and we are not required to include a Compensation Discussion … of options within 60 days after March 15, 2024.
(16)Includes the shares described in footnotes 6 through 15 above.
EXECUTIVE COMPENSATION AND DIRECTOR
S-3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
statements;
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements … ; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute
DRS/A
i5odx qwhp2eg
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
6veels3u7nlxpyrz6 6x
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
dj436m3e3ti010 ql
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next